Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Ferris

Showing results (471-480 of 818) with videos related to

Pageof 82
Sort By:
International Journal of Radiation Oncology, Biology, Physics|June 6, 2006
Posttreatment assessment of response using FDG-PET/CT for patients treated with definitive radiation therapy for head and neck cancersRegiane S Andrade, Dwight E Heron, Berna Degirmenci, et al.
Oral Oncology|March 16, 2013
Linifanib (ABT-869) enhances radiosensitivity of head and neck squamous cell carcinoma cellsHeng-Wei Hsu, Daila S Gridley, Paul D Kim, et al.
Journal of Virology|October 26, 2012
Differential effects of human immunodeficiency virus type 1 capsid and cellular factors nucleoporin 153 and LEDGF/p75 on the efficiency and specificity of viral DNA integrationYasuhiro Koh, Xiaolin Wu, Andrea L Ferris, et al.
Retina (Philadelphia, Pa.)|February 2, 2023
DEFINING "STRONG" VERSUS "WEAK" RESPONSE TO ANTIVASCULAR ENDOTHELIAL GROWTH FACTOR TREATMENT FOR CENTER-INVOLVED DIABETIC MACULAR EDEMAJennifer K Sun, Wesley T Beaulieu, Michele Melia, et al.
Investigative Ophthalmology & Visual Science|May 3, 2008
Oral supplementation of lutein/zeaxanthin and omega-3 long chain polyunsaturated fatty acids in persons aged 60 years or older, with or without AMDLynn L Huang, Hanna R Coleman, Jonghyeon Kim, et al.
Plos One|August 16, 2014
Quantifying metabolic heterogeneity in head and neck tumors in real time: 2-DG uptake is highest in hypoxic tumor regionsErica C Nakajima, Charles Laymon, Matthew Oborski, et al.
Cancer|July 6, 2016
Subsets of salivary duct carcinoma defined by morphologic evidence of pleomorphic adenoma, PLAG1 or HMGA2 rearrangements, and common genetic alterationsSimion I Chiosea, Lester D R Thompson, Ilan Weinreb, et al.
Investigative Ophthalmology & Visual Science|December 20, 2014
Intravitreal sirolimus for the treatment of geographic atrophy: results of a phase I/II clinical trialPhilip A Petrou, Denise Cunningham, Katherine Shimel, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|November 29, 2017
Positive Margins by Oropharyngeal Subsite in Transoral Robotic Surgery for T1/T2 Squamous Cell CarcinomaMichael J Persky, William G Albergotti, Tanya J Rath, et al.
Cancer|April 26, 2016
Confirmation of proposed human papillomavirus risk-adapted staging according to AJCC/UICC TNM criteria for positive oropharyngeal carcinomasZachary D Horne, Scott M Glaser, John A Vargo, et al.
Pageof 82

Showing results (471-480 of 818) with videos related to

Sort By:
Pageof 82
International Journal of Radiation Oncology, Biology, Physics|June 6, 2006
Posttreatment assessment of response using FDG-PET/CT for patients treated with definitive radiation therapy for head and neck cancersRegiane S Andrade, Dwight E Heron, Berna Degirmenci, et al.
Oral Oncology|March 16, 2013
Linifanib (ABT-869) enhances radiosensitivity of head and neck squamous cell carcinoma cellsHeng-Wei Hsu, Daila S Gridley, Paul D Kim, et al.
Journal of Virology|October 26, 2012
Differential effects of human immunodeficiency virus type 1 capsid and cellular factors nucleoporin 153 and LEDGF/p75 on the efficiency and specificity of viral DNA integrationYasuhiro Koh, Xiaolin Wu, Andrea L Ferris, et al.
Retina (Philadelphia, Pa.)|February 2, 2023
DEFINING "STRONG" VERSUS "WEAK" RESPONSE TO ANTIVASCULAR ENDOTHELIAL GROWTH FACTOR TREATMENT FOR CENTER-INVOLVED DIABETIC MACULAR EDEMAJennifer K Sun, Wesley T Beaulieu, Michele Melia, et al.
Investigative Ophthalmology & Visual Science|May 3, 2008
Oral supplementation of lutein/zeaxanthin and omega-3 long chain polyunsaturated fatty acids in persons aged 60 years or older, with or without AMDLynn L Huang, Hanna R Coleman, Jonghyeon Kim, et al.
Plos One|August 16, 2014
Quantifying metabolic heterogeneity in head and neck tumors in real time: 2-DG uptake is highest in hypoxic tumor regionsErica C Nakajima, Charles Laymon, Matthew Oborski, et al.
Cancer|July 6, 2016
Subsets of salivary duct carcinoma defined by morphologic evidence of pleomorphic adenoma, PLAG1 or HMGA2 rearrangements, and common genetic alterationsSimion I Chiosea, Lester D R Thompson, Ilan Weinreb, et al.
Investigative Ophthalmology & Visual Science|December 20, 2014
Intravitreal sirolimus for the treatment of geographic atrophy: results of a phase I/II clinical trialPhilip A Petrou, Denise Cunningham, Katherine Shimel, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|November 29, 2017
Positive Margins by Oropharyngeal Subsite in Transoral Robotic Surgery for T1/T2 Squamous Cell CarcinomaMichael J Persky, William G Albergotti, Tanya J Rath, et al.
Cancer|April 26, 2016
Confirmation of proposed human papillomavirus risk-adapted staging according to AJCC/UICC TNM criteria for positive oropharyngeal carcinomasZachary D Horne, Scott M Glaser, John A Vargo, et al.
Pageof 82